Merck | MRK - Loan Capital



Merck reported EUR6.3B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Adidas EUR 1.91B 2.4B Jun/2025
Adyen EUR 173.32M 6.45M Dec/2024
Akzo Nobel EUR 3.66B 514M Jun/2025
Alcon AG USD 4.66B 68M Jun/2025
Amadeus IT EUR 3.06B 5.2M Jun/2025
Amarin USD 0 0 Mar/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
BASF EUR 18.96B 85M Jun/2025
Bayer EUR 31.71B 3.31B Jun/2025
Beiersdorf EUR 132M 20M Jun/2025
Covestro EUR 2.11B 153M Jun/2025
Danone EUR 10.58B 646M Jun/2025
Fresenius EUR 9.31B 2.08B Jun/2025
Fresenius Medical Care EUR 6.33B 3.18B Jun/2025
Galapagos EUR 6.05M 1.74M Jun/2025
Genmab DKK 132M 3M Jun/2025
Givaudan CHF 4.29B 175M Jun/2024
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
GRIFOLS EUR 7.45B 1.94B Jun/2025
Henkel EUR 2.01B 40M Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Infineon EUR 4.25B 1.17B Jun/2025
Linde USD 19.7B 4.36B Jun/2025
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 6.3B 665M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Philips EUR 7.18B 126M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Sanofi 13.2B 211M Jun/2025
UCB EUR 2.96B 21M Dec/2024